Gilead Sciences, Inc. logo GILD - Gilead Sciences, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 35
HOLD 21
SELL 1
STRONG
SELL
0
| PRICE TARGET: $135.08 DETAILS
HIGH: $150.00
LOW: $105.00
MEDIAN: $135.00
CONSENSUS: $135.08
UPSIDE: 8.14%
Market Cap: 154.97B
Volume: 10,639,074
Avg Volume: 6,805,462
52 Week Range: 91.84-128.7
Sector: Healthcare
Industry: Drug Manufacturers - General
Beta: 0.35
Last Dividend: $3.16
Exchange: NASDAQ
Country: US
Employees: 17,600
IPO Date: 1992-01-22
EPS (TTM): 0.38
P/E Ratio: 239.97
Revenue (TTM): 28.75B
Total Assets: 58.99B
Total Debt: 26.71B
Cash & Equiv: 9.99B
Rev Growth (5Y): 5.1%
EPS Growth (5Y): -38.3%
FCF Growth (5Y): 4.4%
ROCE: 3.5%
Debt/Equity: 1.38

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue 28.75B 27.12B 27.28B 27.30B 24.69B 22.45B 22.13B 26.11B 30.39B 32.64B 24.89B 11.20B
Net Income 480.00M 5.67B 4.59B 6.22B 123.00M 5.39B 5.46B 4.63B 13.50B 18.11B 12.10B 3.08B
EPS 0.38 4.54 3.66 4.96 0.10 4.24 4.20 3.54 10.08 12.37 7.95 2.01
Total Assets 58.99B 62.12B 63.17B 67.95B 68.41B 61.63B 63.67B 70.28B 56.98B 51.72B 34.66B 22.58B
Total Debt 26.71B 24.99B 25.23B 26.70B 31.40B 24.59B 27.32B 33.54B 26.35B 22.05B 12.40B 6.64B
Cash & Equivalents 9.99B 6.08B 5.41B 5.34B 6.00B 11.63B 17.94B 7.59B 8.23B 12.85B 10.03B 2.11B
Operating Cash Flow 10.83B 8.01B 9.07B 11.38B 8.17B 9.14B 8.40B 11.90B 17.05B 21.25B 12.82B 3.10B
Free Cash Flow 10.30B 7.42B 8.34B 10.80B 7.52B 8.32B 7.48B 11.31B 16.30B 20.50B 12.26B 2.92B
FCF per Share 8.26 5.95 6.65 8.60 5.98 6.55 5.76 8.65 12.17 14.00 8.06 1.91
Book Value 19.33B 22.83B 21.24B 21.07B 18.20B 22.52B 21.39B 20.44B 18.89B 18.53B 15.43B 11.37B
Cash & ST Investments 11.57B 7.26B 6.38B 6.52B 7.41B 24.35B 30.09B 25.51B 11.89B 14.61B 10.13B 2.13B
ROC Equity 0.02 0.25 0.22 0.30 0.01 0.24 0.26 0.23 0.71 0.98 0.78 0.27